Pro-BNP versus MEDS Score in Determining the Prognosis of Sepsis Patients; a Diagnostic Accuracy Study
Archives of Academic Emergency Medicine,
Vol. 6 No. 1 (2018),
1 January 2018
,
Page e4
https://doi.org/10.22037/aaem.v6i1.47
Abstract
Introduction:Â Pro-brain natriuretic peptide (Pro-BNP) can act as an independent predictor of mortality in septic patients. This study aimed to compare the diagnostic accuracy of pro-BNP and Mortality in Emergency Department Sepsis (MEDS) score in this regard.
Method:Â This cross-sectional study was conducted on > 14 years old sepsis patients of an emergency department (ED), during 2 years. The level of Pro-BNP and MEDS score were measured for all eligible patients and considering one-month mortality as reference, screening performance characteristics of the two tests were compared using SPSS 21 and STATS 11.
Results: 121 patients with the mean age of 75.87±11.82 years were studied (55.4% male). 85 (70.25%) patients had moderate to high probability of mortality according to MEDS score. The mean Pro-BNP levels of survivor and non-survivor patients were 489.69 ± 327.47 and 3954.98 ± 2717.85 pg/ml, respectively (p < 0.0001). Sensitivity and specificity of Pro-BNP (in 1000 pg/ml cut off) and MEDS score (in level 3) in prediction of 1-month mortality were 93.6 (83.7-97.9), 94.8 (84.7-98.6), 65.0 (51.9-76.3), and 98.2 (89.5-99.9), respectively. Area under the ROC curve of the two tests were 97.36 (95% CI: 92.92-94.48) and 92.31 (95% CI: 86.35-96.53), respectively (p = 0.0543).
Conclusion:Â Pro-BNP and MEDS score both have excellent diagnostic accuracy in predicting 1-month mortality of sepsis patients. However, considering the higher sensitivity as well as availability and ease of calculation, it seems that Pro-BNP can be considered an appropriate tool for screening patients with high risk of mortality following sepsis in ED.
Â
- Pro-brain natriuretic peptide
- sepsis
- mortality
- Emergency department
- dimensional measurement accuracy
How to Cite
References
Gullo A, Bianco N, Berlot G. Management of severe sepsis and septic shock: challenges and recommendations. Critical care clinics. 2006;22(3):489-501.
Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. New England Journal of Medicine. 2003;348(2):138-50.
Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. New England Journal of Medicine. 2001;345(8):588-95.
Lee WL, Slutsky AS. Sepsis and endothelial permeability. The New England journal of medicine. 2010;363(7):689.
Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Critical care medicine. 2001;29(7):1303-10.
Gaieski DF, Edwards JM, Kallan MJ, Carr BG. Benchmarking the incidence and mortality of severe sepsis in the United States. Critical care medicine. 2013;41(5):1167-74.
Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Critical care medicine. 2006;34(6):1589-96.
Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. Jama. 1995;273(2):117-23.
Zambon M, Ceola M, Almeida-de-Castro R, Gullo A, Vincent J-L. Implementation of the Surviving Sepsis Campaign guidelines for severe sepsis and septic shock: we could go faster. Journal of critical care. 2008;23(4):455-60.
Shapiro NI, Wolfe RE, Moore RB, Smith E, Burdick E, Bates DW. Mortality in Emergency Department Sepsis (MEDS) score: a prospectively derived and validated clinical prediction rule. Critical care medicine. 2003;31(3):670-5.
Scheer C, Fuchs C, Rehberg S. Biomarkers in Severe Sepsis and Septic Shock: Just Listen to the Heart? Critical care medicine. 2016;44(4):849-50.
Biteker FS, Çaylak SD, Sözen H. Biomarkers in sepsis. The American journal of emergency medicine. 2016;34(5):924-5.
Brueckmann M, Huhle G, Lang S, Haase KK, Bertsch T, Weiß C, et al. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation. 2005;112(4):527-34.
Maeder M, Fehr T, Rickli H, Ammann P. Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest. 2006;129(5):1349-66.
Levin ER, Gardner DG, Samson WK. Natriuretic peptides. New England Journal of Medicine. 1998;339(5):321-8.
Goetze J, Christoffersen C, Perko M, Arendrup H, Rehfeld J, Kastrup J, et al. Increased cardiac BNP expression associated with myocardial ischemia. The FASEB Journal. 2003;17(9):1105-7.
Januzzi JL, Morss A, Tung R, Pino R, Fifer MA, Thompson BT, et al. Natriuretic peptide testing for the evaluation of critically ill patients with shock in the intensive care unit: a prospective cohort study. Critical care. 2006;10(1):R37.
Roch A, Allardet-Servent J, Michelet P, Oddoze C, Forel J-M, Barrau K, et al. NH2 terminal pro–brain natriuretic peptide plasma level as an early marker of prognosis and cardiac dysfunction in septic shock patients. Critical care medicine. 2005;33(5):1001-7.
Varpula M, Pulkki K, Karlsson S, Ruokonen E, Pettilä V, Group FS. Predictive value of N-terminal pro–brain natriuretic peptide in severe sepsis and septic shock. Critical care medicine. 2007;35(5):1277-83.
Shah KB, Nolan MM, Rao K, Wang DJ, Christenson RH, Shanholtz CB, et al. The characteristics and prognostic importance of NT-ProBNP concentrations in critically ill patients. The American journal of medicine. 2007;120(12):1071-7.
Kotanidou A, Karsaliakos P, Tzanela M, Mavrou I, Kopterides P, Papadomichelakis E, et al. Prognostic importance of increased plasma amino-terminal pro-brain natriuretic peptide levels in a large noncardiac, general intensive care unit population. Shock. 2009;31(4):342-7.
Almog Y, Novack V, Megralishvili R, Kobal S, Barski L, King D, et al. Plasma level of N terminal pro-brain natriuretic peptide as a prognostic marker in critically ill patients. Anesthesia & Analgesia. 2006;102(6):1809-15.
Meyer B, Huelsmann M, Wexberg P, Delle Karth G, Berger R, Moertl D, et al. N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients. Critical care medicine. 2007;35(10):2268-73.
Jefic D, Lee JW, Jefic D, Savoy-Moore RT, Rosman HS. Utility of B-Type Natriuretic Peptide and N-terminal Pro B-Type Natriuretic Peptide in Evaluation of Respiratory Failure in Critically Ill Patients. Chest. 2005;128(1):288-95.
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20(6):864-74.
Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580-637.
Varpula M, Pulkki K, Karlsson S, Ruokonen E, Pettilä V, Group ftFS. Predictive value of N-terminal pro–brain natriuretic peptide in severe sepsis and septic shock*. Critical Care Medicine. 2007;35(5):1277-83.
Alireza Baratloo M, Shokravi M, Saeed Safari M. Predictive value of Glasgow Coma Score and Full Outline of Unresponsiveness Score on the outcome of multiple trauma patients. Archives of Iranian medicine. 2016;19(3):215.
Hermans MAW, Leffers P, Jansen LM, Keulemans YC, Stassen PM. The value of the Mortality in Emergency Department Sepsis (MEDS) score, C reactive protein and lactate in predicting 28-day mortality of sepsis in a Dutch emergency department. Emergency Medicine Journal. 2011.
Kimmoun A, Ducrocq N, Mory S, Delfosse R, Muller L, Perez P, et al. Cardiac contractile reserve parameters are related to prognosis in septic shock. BioMed research international. 2013;2013.
Rudiger A, Gasser S, Fischler M, Hornemann T, von Eckardstein A, Maggiorini M. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure*. Critical Care Medicine. 2006;34(8):2140-4.
Charpentier J, Luyt C-E, Fulla Y, Vinsonneau C, Cariou A, Grabar S, et al. Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Critical care medicine. 2004;32(3):660-5.
Post F, Weilemann LS, Messow C-M, Sinning C, Münzel T. B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients. Critical care medicine. 2008;36(11):3030-7.
Kuo SH, Lee YT, Li CR, Tseng CJ, Chao WN, Wang PH, et al. Mortality in Emergency Department Sepsis score as a prognostic indicator in patients with pyogenic liver abscess. Am J Emerg Med. 2013;31(6):916-21.
Hermans M, Leffers P, Jansen L, Keulemans Y, Stassen P. The value of the Mortality in Emergency Department Sepsis (MEDS) score, C reactive protein and lactate in predicting 28-day mortality of sepsis in a Dutch emergency department. Emerg Med J. 2012;29(4):295-300.
Macdonald SP, Arendts G, Fatovich DM, Brown SG. Comparison of PIRO, SOFA, and MEDS scores for predicting mortality in emergency department patients with severe sepsis and septic shock. Academic Emergency Medicine. 2014;21(11):1257-63.
- Abstract Viewed: 308 times
- PDF Downloaded: 175 times
- HTML Downloaded: 87 times
